Toyos, Melissa
DiVito, Melinda
Messmer, Elisabeth M.
McGee, Selina
Peterson, Jared
Patel, Assem
Pattar, Guruprasad
Evans, David G.
Vollmer, Patrick M.
Wesley, Gina
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Multicenter Randomized Double-Masked Study Comparing Preservative-free Brimonidine Tartrate Ophthalmic Solution 0.025% with LUMIFY® 0.025% for Ocular Redness in Adults
https://doi.org/10.1007/s40123-025-01194-z
Article History
Received: 10 May 2025
Accepted: 17 June 2025
First Online: 25 July 2025
Declarations
:
: Melissa Toyos is a clinical investigator, speaker and consultant for Bausch + Lomb and Mallinckrodt, a clinical investigator and consultant for Dompé and Sun Pharma, and a clinical investigator for Kala Pharmaceuticals, Glaukos and CBCC Global. Melinda DiVito is an employee of Bausch + Lomb Inc.; Patrick M. Vollmer is a clinical investigator and speaker for Bausch + Lomb; Elisabeth M. Messmer is a speaker for: Alcon, Bausch + Lomb, Bayer, Dompé, Fidia, GlaxoSmithKline, Novartis, OmniVision, Sanofi, Santen GmbH, Théa Pharma GmbH, TRB-Chemedica AG, Ursapharm, and Visufarma, and a consultant for: Alcon, Alfa Intes, DMG, Dompé, Kala, Novaliq, Novartis, Santen GmbH, Senju, Shire, Sifi, Sun, Théa Pharma GmbH, TRB-Chemedica AG, Viatris, and Visufarma. Selina McGee, Jared Peterson, Assem Patel, Guruprasad Pattar, David G. Evans, and Gina Wesley have nothing to disclose.
: The study was conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonization guidelines, the principals of Good Clinical Practice, and applicable local regulatory requirements. The study protocol, informed consent form, and other information provided to participants, and all appropriate amendments were properly reviewed and approved by an Institutional Review Board (Alpha IRB, 1001 Avenida Pico, San Clemente, CA 92673).